Madrigal Pharmaceuticals Other Long Term Liabilities (Quarterly) Insights

Madrigal Pharmaceuticals, Inc. (MDGL)

503.64 +9.74 (+1.97%) USD | NASDAQ | Jan 14, 14:41

View Other Long Term Liabilities (Quarterly) for MDGL.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Eli Lilly & Co.	Upgrade
Amgen, Inc.	Upgrade
Pfizer Inc.	Upgrade
Crinetics Pharmaceuticals, Inc.	Upgrade
Amicus Therapeutics, Inc.	Upgrade